Skip to main content
Livermore
Livermore
ZHEN

Clark Estates Inc

SEC CIK
0001056466
Latest filing
Aug 5, 2026

The latest 13F from Clark Estates Inc covers Q2 2026 (filed Aug 5, 2026): 90 long positions worth $433.7M. The top 10 holdings make up 52.8% of the portfolio, and the largest is Ea Series Trust at 15.4%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
11
Est. +$51.9M
Added
17
Est. +$31.5M
Reduced
16
Est. −$44.1M
Sold out
18
Est. −$41.8M

Top 5 holdings

Share of this quarter's portfolio value

  1. Ea Series Trust02072L466
    15.4%$66.7M
  2. Vanguard Ftse Developed Markets ETF921943858
    6.1%$26.4M
  3. ULUnilever PLC
    5.1%$22.2MHistory
  4. DISWalt Disney Co
    4.4%$19.3MHistory
  5. AMRZAmrize Ltd
    4.0%$17.3MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. Vanguard Ftse Developed Markets ETF921943858
    +$26.4MNew
  2. HSICHenry Schein Inc
    +$10.6MAddedHistory
  3. ULUnilever PLC
    +$3.91MAddedHistory
  4. BBYBest Buy Co Inc
    +$3.32MNewHistory
  5. AOSSmith A O Corp
    +$2.89MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Vanguard Ftse Developed Markets ETF921943858
    +6.10 pp0.0% → 6.1%
  2. HSICHenry Schein Inc
    +2.46 pp0.1% → 2.6%History
  3. ULUnilever PLC
    +0.95 pp4.2% → 5.1%History
  4. BBYBest Buy Co Inc
    +0.76 pp0.0% → 0.8%History
  5. AOSSmith A O Corp
    +0.67 pp0.0% → 0.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. Ea Series Trust02072L466
    −$15.3MReduced
  2. AVNSAvanos Medical, Inc.
    −$11.8MSold outHistory
  3. IQVIQVIA Holdings Inc.
    −$8.31MReducedHistory
  4. SOLVSolventum Corp
    −$6.94MReducedHistory
  5. MDTMedtronic plc
    −$5.08MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Ea Series Trust02072L466
    −3.13 pp18.5% → 15.4%
  2. AVNSAvanos Medical, Inc.
    −2.84 pp2.8% → 0.0%History
  3. MDTMedtronic plc
    −1.60 pp3.2% → 1.6%History
  4. IQVIQVIA Holdings Inc.
    −1.58 pp3.9% → 2.3%History
  5. SOLVSolventum Corp
    −0.99 pp4.5% → 3.6%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$433.7M
+$17.5M (+4.2%) vs. prior quarter
Positions
90
−7 vs. prior quarter
Top 10 concentration
52.8%
Top 10 as share of value
Turnover
19.6%
Q2 2026, one quarter
Average holding period
8.4 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $782.7M (Q1 2021)

Q1 2021: $782.7MQ2 2021: $765.6MQ3 2021: $700.6MQ4 2021: $683.4MQ1 2022: $633.7MQ2 2022: $577.7MQ3 2022: $452.5MQ4 2022: $481.3MQ1 2023: $503.7MQ2 2023: $593.2MQ3 2023: $549.6MQ4 2023: $590.3MQ1 2024: $607.1MQ2 2024: $532.5MQ3 2024: $537.3MQ4 2024: $517.4MQ1 2025: $472.3MQ2 2025: $445.7MQ3 2025: $437.7MQ4 2025: $412.1MQ1 2026: $416.2MQ2 2026: $433.7M
Q1 2021Q2 2026
13F filings of Clark Estates Inc by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 5, 202690$433.7MEa Series TrustVanguard Ftse Developed Markets ETFULvs. Q1 2026SEC
Q1 2026May 11, 202697$416.2MEa Series TrustDISSOLVvs. Q4 2025SEC
Q4 2025Feb 12, 202698$412.1MEa Series TrustDISHLNvs. Q3 2025SEC
Q3 2025Nov 10, 202599$437.7MEa Series TrustIQVMDTvs. Q2 2025SEC
Q2 2025Aug 11, 202597$445.7MEa Series TrustIQVBAXvs. Q1 2025SEC
Q1 2025May 8, 202594$472.3MEa Series TrustBAXSNNvs. Q4 2024SEC
Q4 2024Feb 6, 202592$517.4MEa Series TrustDNBBAXvs. Q3 2024SEC
Q3 2024Nov 13, 202490$537.3MEa Series TrustDNBMDTvs. Q2 2024SEC
Q2 2024Aug 8, 202486$532.5MEa Series TrustDNBPMvs. Q1 2024SEC
Q1 2024May 7, 202488$607.1MEa Series TrustKVUEDNBvs. Q4 2023SEC
Q4 2023Feb 12, 202488$590.3MEa Series TrustDNBGEHCvs. Q3 2023SEC
Q3 2023Nov 13, 202390$549.6MEa Series TrustHLNDNBvs. Q2 2023SEC
Q2 2023Aug 11, 202393$593.2MEa Series TrustFISVULvs. Q1 2023SEC
Q1 2023May 12, 202388$503.7MFISVULHLNvs. Q4 2022SEC
Q4 2022Feb 8, 202384$481.3MFISVULHLNvs. Q3 2022SEC
Q3 2022Nov 15, 2022Amended84$452.5MFISVULMDTvs. Q2 2022SEC
Q2 2022Aug 8, 202294$577.7MULGOOGLFISVvs. Q1 2022SEC
Q1 2022May 13, 202290$633.7MVZPMCAHvs. Q4 2021SEC
Q4 2021Feb 14, 202290$683.4MMETADDDVZvs. Q3 2021SEC
Q3 2021Nov 12, 202192$700.6MGOOGLDDDMETAvs. Q2 2021SEC
Q2 2021Aug 10, 202192$765.6MDDDMETAGOOGLvs. Q1 2021SEC
Q1 2021May 14, 202195$782.7MMETASTTKDDD–SEC